Perfluorooctanoic acid induces transcriptomic alterations in second trimester human cytotrophoblasts
Toxicological Sciences · 28.11.2023 · 196 (2) · 187-199
DOI: 10.1093/toxsci/kfad097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 20.09.2023. Verfasst von Hao Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF), San…. Hauptthemen laut MEDLINE: Fluorocarbons, Alkanesulfonic Acids. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIEHS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Poly- and perfluroroalkylated substances (PFAS) are a major class of surfactants used in industry applications and consumer products. Despite efforts to reduce the usage of PFAS due to their environmental persistence, compounds such as perfluorooctanoic acid (PFOA) are widely detected in human blood and tissue. Although growing evidence supports that prenatal exposures to PFOA and other PFAS are linked to adverse pregnancy outcomes, the target organs and pathways remain unclear. Recent investigations in mouse and human cell lines suggest that PFAS may impact the placenta and impair trophoblast function. In this study, we investigated the effects of PFOA on cytotoxicity and the transcriptome in cultured second trimester human cytotrophoblasts (CTBs). We show that PFOA significantly reduces viability and induces cell death at 24 h, in a concentration-dependent manner. At subcytotoxic concentrations, PFOA impacted expression of hundreds of genes, including several molecules (CRH, IFIT1, and TNFSF10) linked with lipid metabolism and innate immune response pathways. Furthermore, in silico analyses suggested that regulatory factors such as peroxisome proliferator-activated receptor-mediated pathways may be especially important in response to PFOA. In summary, this study provides evidence that PFOA alters primary human CTB viability and gene pathways that could contribute to placental dysfunction and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF), San Francisco, California 94143, USA.
- Program on Reproductive Health and the Environment, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF), San Francisco, California 94143, USA.
ORCID-Profile: Hao Chen, Joshua F Robinson
Förderung
- NIAID NIH HHS
- NIEHS NIH HHS
- NIH HHS
- California Environmental Protection Agency
- United States Environmental Protection Agency
- National Institutes of Environmental Health Sciences
- California Preterm Birth Initiative
- National Institutes of Health
Zitieren
APA
Chen, H., Kapidzic, M., Gantar, D., Aksel, S., Levan, J., Abrahamsson, D. P., Jigmeddagva, U., Basrai, S., San, A., Gaw, S. L., Woodruff, T. J., Fisher, S. J., & Robinson, J. F. (2023). Perfluorooctanoic acid induces transcriptomic alterations in second trimester human cytotrophoblasts. Toxicological Sciences, 196(2), 187-199. https://doi.org/10.1093/toxsci/kfad097
Vancouver
Chen H, Kapidzic M, Gantar D, Aksel S, Levan J, Abrahamsson DP, et al. Perfluorooctanoic acid induces transcriptomic alterations in second trimester human cytotrophoblasts. Toxicological Sciences. 2023;196(2):187-199. doi:10.1093/toxsci/kfad097
BibTeX
@article{Chen2023,
author = {Chen, Hao and Kapidzic, Mirhan and Gantar, Danielle and Aksel, Sena and Levan, Justine and Abrahamsson, Dimitri P and Jigmeddagva, Unurzul and Basrai, Sanah and San, Ali and Gaw, Stephanie L and Woodruff, Tracey J and Fisher, Susan J and Robinson, Joshua F},
title = {Perfluorooctanoic acid induces transcriptomic alterations in second trimester human cytotrophoblasts},
journal = {Toxicological Sciences},
year = {2023},
volume = {196},
number = {2},
pages = {187--199},
doi = {10.1093/toxsci/kfad097}
}
EUVIMED